GAN&LEE PHARMACEUTICALS CO LTD

GAN&LEE PHARMACEUTICALS CO LTD — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
+Revenue	3.0B	2.6B	1.7B	3.6B	3.4B	2.9B	2.4B	2.4B	1.8B	1.2B	927.0M	693.0M
Revenue Growth %	16.8%	52.3%	-52.6%	7.4%	16.1%	21.3%	0.7%	33.9%	45.2%	31.6%	33.8%	--
Total Revenue	3.0B	2.6B	1.7B	3.6B	3.4B	2.9B	2.4B	2.4B	1.8B	1.2B	927.0M	693.0M
Cost Of Revenue	767.0M	697.0M	406.0M	396.0M	307.0M	238.0M	188.0M	205.0M	166.0M	109.0M	82.4M	67.4M
+Gross Profit	2.3B	1.9B	1.3B	3.2B	3.1B	2.7B	2.2B	2.2B	1.6B	1.1B	844.6M	625.6M
Gross Margin %	74.8%	73.3%	76.3%	89.0%	90.9%	91.8%	92.1%	91.4%	90.6%	91.1%	91.1%	90.3%
Total Operating Cost	2.7B	2.4B	2.3B	2.0B	1.9B	1.6B	1.3B	1.1B	882.0M	707.0M	590.0M	464.0M
Selling Expenses	1.2B	946.0M	1.1B	1.0B	915.0M	796.0M	720.0M	593.0M	472.0M	437.0M	342.0M	277.0M
Admin Expenses	256.0M	217.0M	247.0M	299.0M	286.0M	279.0M	218.0M	171.0M	230.0M	145.0M	148.0M	106.0M
Rd Expenses	541.0M	501.0M	562.0M	475.0M	420.0M	236.0M	143.0M	137.0M	--	--	--	--
Finance Expenses	-98.3M	-78.7M	-94.3M	-177.0M	-574,200	7.5M	530,000	1.7M	-935,800	3.9M	925,400	1.7M
+Operating Income	632.0M	315.0M	-569.0M	1.7B	1.5B	1.4B	1.1B	1.3B	900.0M	522.0M	347.0M	234.0M
Operating Margin %	20.8%	12.1%	-33.2%	47.0%	43.2%	48.3%	46.7%	53.6%	50.8%	42.8%	37.4%	33.8%
Non Operating Income	2.8M	4.1M	2.9M	2.5M	530,200	656,900	38,800	385,800	7.9M	4.1M	8.6M	7.8M
Non Operating Expenses	4.0M	13.3M	16.5M	5.4M	8.0M	1.1M	602,300	2.1M	1.1M	486,600	679,100	265,300
Investment Income	61.2M	63.3M	87.6M	140.0M	63.2M	46.2M	23.3M	11.6M	10.9M	9.0M	10.8M	5.7M
Fair Value Change Income	157.0M	-17.9M	-80.7M	-54.5M	-42.8M	22.4M	--	--	--	--	--	--
Asset Disposal Income	1.9M	339,300	485,800	-1,000	329,700	-1.7M	82,300	--	--	--	--	--
Asset Impairment Loss	15.7M	39.8M	79.0M	3.8M	3.2M	--	27.5M	2.5M	5.8M	2.3M	2.9M	1.6M
Other Income	27.0M	24.0M	46.6M	46.2M	17.3M	9.4M	13.6M	9.5M	--	--	--	--
Income Before Tax	630.0M	306.0M	-582.0M	1.7B	1.4B	1.4B	1.1B	1.3B	907.0M	526.0M	355.0M	241.0M
Income Tax	15.7M	-34.1M	-143.0M	243.0M	215.0M	230.0M	180.0M	188.0M	137.0M	78.4M	50.2M	36.7M
+Net Income	615.0M	340.0M	-440.0M	1.5B	1.2B	1.2B	934.0M	1.1B	770.0M	447.0M	305.0M	205.0M
Net Margin %	20.2%	13.0%	-25.7%	40.2%	36.6%	40.3%	39.1%	45.6%	43.5%	36.6%	32.9%	29.6%
Net Income Attributable	615.0M	340.0M	-440.0M	1.5B	1.2B	1.2B	934.0M	1.1B	770.0M	447.0M	305.0M	205.0M
Minority Interest	-46.00	162,900	-23.00	-200.00	-72.00	-70.00	-69.00	-4,000	-13,700	-28,200	-162,000	-3,200
Eps Basic	1.04	0.60	-0.78	2.59	2.31	2.31	2.59	2.99	2.13	1.24	0.85	0.61
Eps Diluted	1.04	0.60	-0.78	2.59	2.31	2.31	2.59	2.99	2.13	1.24	0.85	0.61

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash And Equivalents	903.0M	2.4B	2.9B	3.3B	2.8B	483.0M	594.0M	817.0M	535.0M	112.0M	245.0M	232.0M
Trading Financial Assets	1.5B	2.4B	1.6B	1.6B	787.0M	1.1B	--	--	--	--	--	--
Accounts Receivable	214.0M	384.0M	176.0M	934.0M	827.0M	844.0M	750.0M	401.0M	358.0M	229.0M	188.0M	176.0M
Notes Receivable	12.2M	--	--	--	--	--	76.5M	76.3M	21.8M	15.6M	39.4M	--
Notes And Accounts Receivable	226.0M	384.0M	176.0M	934.0M	827.0M	844.0M	827.0M	477.0M	380.0M	244.0M	228.0M	176.0M
Prepayments	56.6M	41.0M	46.0M	62.1M	70.2M	36.9M	30.3M	18.7M	14.4M	14.2M	8.3M	8.9M
Inventory	1.1B	861.0M	649.0M	651.0M	493.0M	471.0M	389.0M	212.0M	146.0M	123.0M	79.9M	80.8M
Total Current Assets	3.8B	6.2B	5.7B	6.9B	6.0B	3.1B	2.4B	2.0B	1.3B	848.0M	575.0M	506.0M
Fixed Assets	--	1.9B	1.6B	1.7B	1.7B	1.5B	1.0B	658.0M	313.0M	110.0M	105.0M	99.8M
Fixed Assets Total	2.6B	1.9B	1.6B	1.7B	1.7B	1.5B	1.0B	658.0M	313.0M	110.0M	105.0M	99.8M
Construction In Progress	--	2.0B	2.0B	873.0M	408.0M	381.0M	599.0M	729.0M	659.0M	673.0M	142.0M	28.5M
Construction In Progress Total	1.3B	2.0B	2.0B	875.0M	410.0M	383.0M	601.0M	733.0M	659.0M	673.0M	142.0M	28.6M
Intangible Assets	273.0M	278.0M	293.0M	296.0M	239.0M	132.0M	136.0M	138.0M	141.0M	144.0M	148.0M	147.0M
Long Term Deferred Expenses	7.1M	8.9M	10.6M	12.4M	13.6M	15.4M	--	--	--	--	--	--
Total Non Current Assets	8.3B	5.5B	4.9B	4.0B	3.5B	2.9B	2.3B	1.8B	1.3B	964.0M	627.0M	327.0M
Total Assets	12.0B	11.7B	10.6B	10.9B	9.5B	6.0B	4.7B	3.7B	2.6B	1.8B	1.2B	833.0M
Short Term Borrowings	--	--	--	--	--	--	--	--	--	50,000	19.0M	2.0M
Accounts Payable	129.0M	106.0M	44.7M	37.7M	17.8M	30.7M	39.3M	31.2M	36.8M	14.6M	6.4M	2.0M
Advance Receipts	--	--	603,600	--	--	90.7M	7.2M	10.0M	7.3M	5.4M	414,200	94,400
Contract Liabilities	63.3M	53.0M	68.1M	36.6M	68.4M	--	--	--	--	--	--	--
Total Current Liabilities	801.0M	773.0M	813.0M	486.0M	410.0M	458.0M	354.0M	336.0M	271.0M	188.0M	123.0M	61.8M
Long Term Borrowings	--	--	--	--	--	--	--	--	--	60.8M	--	--
Total Non Current Liabilities	187.0M	199.0M	208.0M	200.0M	159.0M	97.7M	69.9M	72.2M	76.6M	137.0M	41.2M	37.5M
Total Liabilities	988.0M	973.0M	1.0B	686.0M	569.0M	556.0M	424.0M	408.0M	348.0M	325.0M	164.0M	99.3M
Paid In Capital	601.0M	594.0M	566.0M	562.0M	562.0M	361.0M	361.0M	361.0M	335.0M	335.0M	335.0M	335.0M
Capital Reserve	3.6B	3.4B	2.6B	2.5B	2.5B	72.7M	72.7M	72.7M	98.6M	98.6M	98.6M	98.6M
Surplus Reserve	301.0M	297.0M	292.0M	292.0M	292.0M	292.0M	292.0M	292.0M	184.0M	109.0M	66.5M	34.3M
Retained Earnings	6.8B	6.6B	6.2B	6.8B	5.6B	4.7B	3.5B	2.6B	1.6B	943.0M	538.0M	265.0M
Minority Equity	--	400.00	-162,500	-162,500	-162,300	-162,200	-162,100	-162,100	-158,100	-144,300	-116,100	45,800
Equity Attributable	11.1B	10.7B	9.6B	10.2B	8.9B	5.5B	4.3B	3.3B	2.3B	1.5B	1.0B	733.0M
Total Equity	11.1B	10.7B	9.6B	10.2B	8.9B	5.5B	4.3B	3.3B	2.3B	1.5B	1.0B	733.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash From Sales	3.3B	2.4B	2.5B	3.5B	3.4B	3.0B	1.9B	2.3B	1.7B	1.4B	1.0B	779.0M
Tax Refunds Received	67.5M	122.0M	121.0M	8.9M	2.7M	572,000	--	898,300	983,000	--	--	--
Total Operating Cash Inflow	3.4B	2.6B	2.7B	3.5B	3.4B	3.0B	1.9B	2.4B	1.7B	1.4B	1.0B	786.0M
Cash Paid For Goods	878.0M	848.0M	554.0M	472.0M	362.0M	322.0M	294.0M	279.0M	126.0M	113.0M	45.2M	68.0M
Cash Paid To Employees	869.0M	748.0M	677.0M	621.0M	483.0M	460.0M	378.0M	292.0M	233.0M	209.0M	168.0M	139.0M
Taxes Paid	168.0M	117.0M	238.0M	333.0M	442.0M	262.0M	223.0M	275.0M	176.0M	161.0M	188.0M	160.0M
Total Operating Cash Outflow	2.9B	2.5B	2.4B	2.5B	2.2B	1.8B	1.5B	1.4B	1.0B	875.0M	731.0M	619.0M
Operating Cash Flow	537.0M	109.0M	297.0M	1.1B	1.2B	1.2B	418.0M	950.0M	686.0M	502.0M	296.0M	167.0M
Total Investing Cash Inflow	8.9B	7.6B	4.8B	3.2B	7.0B	5.0B	4.0B	3.3B	1.4B	2.3B	3.4B	3.2B
Total Investing Cash Outflow	9.1B	8.6B	5.3B	3.7B	10.2B	6.2B	4.7B	4.0B	2.0B	3.0B	3.7B	3.2B
Investing Cash Flow	-262.0M	-977.0M	-442.0M	-498.0M	-3.2B	-1.2B	-691.0M	-726.0M	-593.0M	-680.0M	-338.0M	-63.2M
Cash From Borrowings	--	--	--	--	--	--	--	--	--	44.3M	19.0M	2.6M
Dividends And Interest Paid	421.0M	--	168.0M	225.0M	201.0M	--	--	1.7M	2.3M	2.8M	282,700	26.2M
Debt Repayments	--	--	--	--	--	--	--	29.7M	36.8M	500,000	2.0M	4.6M
Total Financing Cash Inflow	139.0M	760.0M	71.4M	--	2.4B	--	--	--	--	62.8M	19.0M	2.6M
Total Financing Cash Outflow	440.0M	5.0M	172.0M	229.0M	201.0M	--	--	31.4M	39.1M	3.3M	20.8M	30.8M
Financing Cash Flow	-301.0M	755.0M	-101.0M	-229.0M	2.2B	--	--	-31.4M	-39.1M	59.5M	-1.8M	-28.2M
Net Change In Cash	-26.4M	-111.0M	-242.0M	348.0M	258.0M	-13.2M	-271.0M	190.0M	55.1M	-116.0M	-43.1M	75.6M
Ending Cash Balance	260.0M	286.0M	397.0M	640.0M	291.0M	33.2M	46.4M	317.0M	127.0M	72.3M	188.0M	232.0M
Capex	441.0M	553.0M	983.0M	692.0M	582.0M	407.0M	513.0M	431.0M	258.0M	368.0M	315.0M	100.0M